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and induces papillary apoptosis in dehydrated rats1
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Chronic COX-2 inhibition reduces medullary HSP70 expres-
sion and induces papillary apoptosis in dehydrated rats.
Background. Papillary cells adapt to their hyperosmotic en-
vironment by accumulating organic osmolytes and by enhanced
synthesis of heat shock protein 70 (HSP70), which protect
against high-solute concentrations. Because cyclooxygenase-2
(COX-2) is expressed abundantly in the renal papilla and is in-
duced by dehydration, and because HSP70 expression is stimu-
lated by specific prostaglandins, COX-2 inhibition may interfere
with cellular osmoadaptation.
Methods. In vivo, rats received rofecoxib before wa-
ter deprivation. Medullary expression of several tonicity-
responsive genes was analyzed and apoptosis was monitored by
transferase-mediated dUTP nick-end labeled (TUNEL) stain-
ing and determination of papillary caspase-3 activity. In vitro,
inner medullary collecting duct 3 (IMCD3) cells were exposed
to hyertonic medium containing a COX-2-specific inhibitor.
Thereafter, expression of tonicity-responsive genes was ana-
lyzed and resistance to high-solute concentrations was exam-
ined. Further, the effect of 12-PGJ2, a urinary prostaglandin,
and of HSP70 overexpression on resistance against high urea
concentration, was evaluated.
Results. Rofecoxib treatment significantly increased urine os-
molality due to higher urea concentrations, but reduced pap-
illary HSP70 abundance by 50%. TUNEL staining showed
numerous apoptotic cells in the papilla, associated with in-
creased caspase-3 activity. These in vivo results were confirmed
by experiments on cultured IMCD3 cells, in which COX-2 in-
hibition impaired the tonicity-induced up-regulation of HSP70
expression and rendered the cells susceptible to high urea con-
centrations. Furthermore, 12-PGJ2 increased both HSP70 ex-
pression and resistance against high urea, which was causally
linked to higher HSP70 levels.
Conclusion. These observations support the view that chronic
COX-2 inhibition reduces medullary HSP70 expression, thus
rendering papillary cells susceptible to damage by high urea
concentrations, especially when accompanied by dehydration.
1See Editorial by Aufricht, p. 739.
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The mammalian renal inner medulla is essential for the
production of concentrated or diluted urine, thus provid-
ing the basis for the proper maintenance of an osmolality
close to 290 mOsm/kg H2O in the extracellular fluid, even
when water intake varies widely. As a consequence, in-
ner medullary cells are exposed to highly fluctuating NaCl
and urea concentrations. These cells must not only survive
in this harsh environment but also function normally.
In situations when the urine concentrating mecha-
nism is stimulated, the papillary interstitial osmolal-
ity increases steeply [1]. The two major medullary
solutes, NaCl and urea, however, differ substantially in
their effectiveness as osmotic agents [2]. While NaCl
remains largely in the extracellular space, urea enters
the cells rapidly. Thus, high extracellular salt concen-
trations induce cell shrinkage and a rise in intracellu-
lar ionic strength, the latter causing DNA double-strand
breaks and apoptosis [3, 4]. It is well established that,
in the long term, renal medullary cells achieve osmotic
equilibrium with high extracellular salt concentrations
by accumulation of compatible organic osmolytes [2].
These molecules reduce the stress of hypertonicity by
lowering cellular ionic strength by replacing intracellular
electrolytes and allowing recovery of cell volume and
intracellular ionic strength to normal levels without in-
terfering negatively with cellular functions [2, 5]. In
contrast, urea enters the cells rapidly and thus consti-
tutes no major osmotic stress. Urea, however, at concen-
trations routinely observed in the renal inner medulla
during antidiuresis, is a potent protein-destabilizing agent
which reduces the activity of various enzymes and induces
apoptosis in cells that are not adequately protected [6–8].
Interestingly, heat shock protein 70 (HSP70), a chaper-
one abundantly expressed in the renal papilla, confers
resistance against the adverse effects of high urea con-
centrations to renal medullary cells and counteracts urea-
mediated inhibition of enzymes [7, 8]. During the past few
years it has become increasingly clear that the osmotic
induction of both the genes involved in osmolyte accu-
mulation and of HSP70 is mediated by TonEBP/NFAT5,
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a transcriptional activator that is essential for the
expression of these target genes in response to hyper-
tonicity [9, 10]. The regulation of HSP70 expression, how-
ever, appears to be more complex than that of other
TonEBP/NFAT5 target genes [11].
Recent studies demonstrate that the renal medulla
is an active site for both production and action of
prostaglandins (PGs). The two COX isoforms, COX-1
and COX-2, expressed in kidney, are encoded by genes
sharing about 60% homology but are generally similar in
terms of their enzymatic properties [12, 13]. In contrast to
many other tissues, COX-2 is expressed constitutively in
the renal inner medulla and was detected in both papillary
interstitial and collecting duct cells, in vivo and in vitro
[14, 15], implying important paracrine and/or autocrine
effects of COX-2–derived products. Several studies sug-
gest that COX-2 is the major COX isoform contributing
to medullary prostaglandin generation in vivo, in partic-
ular in dehydrated subjects [14, 15].
In addition to prostanoids such as PGE2, PGF2a , PGI2,
and PGD2, which modulate a variety of aspects of re-
nal physiology, including tubular sodium, water, and urea
transport, renal hemodynamics, and renin secretion from
juxtaglomerular cells [16–18], cyclopentenone-PGs like
12-PGJ2, which is formed from PGD2 by nonenzymatic
dehydration and is excreted in human urine in signifi-
cant amounts [19], might exert biologic effects on renal
medullary cells. In contrast to other PGs, 12-PGJ2 is a
potent inducer of HSP70 expression by direct activation
of heat shock transcription factor 1 (HSF1) rather than
classic signaling through cell surface receptors [20, 21]
and may stimulate HSP70 expression in response to hy-
pertonicity and contribute to resistance against high urea
concentrations in the renal medulla. Thus, it is conceiv-
able that repression of this pathway by COX-2 inhibitors
interferes with osmoadaptation of renal papillary cells,
in particular in situations when the urinary concentrating
mechanism is stimulated.
METHODS
Animal studies
The effect of chronic COX-2 inhibition was investi-
gated in male Wistar rats with a starting weight of 150–
200 g (Charles River Laboratories, Sulzfeld, Germany).
The animals received rofecoxib (MSD Sharp & Dohme,
Haar, Germany) suspended in a solution containing 0.5%
xanthan gum and given via the drinking water at a daily
dosage of 5 mg/kg body weight or control suspension
(same solution but lacking rofecoxib) for 3 weeks. Be-
fore the beginning of the experiment and at weeks 1
and 2, the animals were placed in metabolic cages for
24 hours to allow collection of urine. During the last
24 hours of the experiment (week 3), the animals were
water deprived and again placed in metabolic cages for
collection of urine. After this period, the animals were
anesthesized with pentobarbitone sodium (0.6 mg/kg in-
traperitoneally), the kidneys quickly removed and pro-
cessed for further analyses. For Western and Northern
blot analyses and for determination of caspase-3 ac-
tivity, the white inner medullae were dissected on ice,
snap frozen in liquid nitrogen, and stored at −80◦C. For
in situ detection of apoptotic cells, 2-mm thick kidney
slices were cut along the cortico-medullary axis, fixed
overnight in phosphate-buffered saline (PBS) contain-
ing 3.7% paraformaldehyde, and embedded in paraffin.
Based on previous observations, this method was equally
effective as perfusion fixation. For electron microprobe
analysis, the inner medulla was excised rapidly and frozen
in a mixture of propane and isopentane (3:1 v/v, −196◦C).
All experiments were conducted in accordance with
German federal laws relating to animal experimentation.
Cell culture
Murine IMCD3 cells were kindly provided by Dr. S.R.
Gullans and maintained under standard conditions. For
Western and Northern blot analyses, the cells were plated
on 60-mm plastic dishes (BD Biosciences, Grenoble,
France) or, for survival assays, in 24-well plates (Costar,
Cambridge, MA, USA), and grown to confluence. Sub-
sequently, they were treated for 4 hours with 10 lmol/L
12-PGJ2 (Cayman Chemicals, Ann Arbor, MI, USA)
dissolved in methylacetate or with vehicle alone (con-
trol) followed by a 20-hour reincubation period in nor-
mal medium. After this period, HSP70 expression and
cell survival in medium containing 400 mmol/L urea was
assessed (see below).
To test the consequences of COX-2 inhibition on the
protective effect hypertonic pretreatment against high
urea concentrations, IMCD3 cells were pretreated for
48 hours in medium made hypertonic by the addition of
100 mmol/L NaCl (final osmolality 500 mOsm/kg H2O)
in the presence of 10 lmol/L NS398, a highly specific
COX-2 inhibitor with improved solubility in aqueous
media compared with rofecoxib, thus requiring only a
low volume of organic solvents. NS398 was dissolved in
ethanol as a 20-mmol/L stock solution and diluted 1:2000
in hypertonic medium. Appropriate controls were incu-
bated with the same volume of ethanol in the hypertonic
medium. All media contained 10 lmol/L arachidonic
acid. After 48 hours, the cells were either processed for
analysis of HSP70, Na- and Cl-dependent betaine trans-
porter (BGT1) and aldose reductase (AR) expression,
or further incubated in medium containing an additional
400 mmol/L urea. After 24 hours, the number of surviving
cells was determined (see below).
To address the effect of COX-2 inhibition on prolifera-
tion of IMCD3 cells in hypertonic medium, exponentially
growing IMCD3 cells were plated at a density of 1 × 105
cells per 60-mm dish. 24 hours later, the medium was
replaced with hypertonic medium (+100 mmol/L NaCl;
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final osmolality 500 mOsm/kg H2O) in the presence of
10 lmol/L NS 398 or vehicle. The cell number was deter-
mined daily after trysinization using a hemocytometer.
Expression vectors and transfection
To achieve stable overexpression of HSP70 along with
a marker gene allowing rapid identification of positive
clones in vivo, a bicistronic expression vector was con-
structed. First, a 2.1-kb fragment containing the entire
coding region of the human stress-inducible HSP70 was
released from pAT-ph2.3 (kindly provided by Dr. R.I.
Morimoto) [22] with Bam HI and Sca I. The HSP70
fragment was subsequently inserted into the respec-
tive sites of pIRES-hrGFP-1a (Stratagene, Amsterdam,
The Netherlands) resulting in the addition of an en-
cephalomycarditis virus–derived internal ribosome en-
try site (IRES) and a humanized, nontoxic variant of
green fluorescent protein derived from Renilla (hrGFP)
to the 3′-end. The sequences containing HSP70-IRES-
hrGFP but lacking promoter and polyadenylation sites
were released from this construct with Bam HI and Hpa I
and blunt-end ligated into Bam HI/Hind III-cut pcDNA5
(Invitrogen, Heidelberg, Germany), which added a cy-
tomegalovirus (CMV) promoter at the 5′-end and an
SV40 polyadenylation sequence at the 3′-end, along with
resistance genes for hygromycin and ampicillin. For mock
transfection, the same construct lacking HSP70 was pre-
pared (see also Fig. 9).
Exponentially growing IMCD3 were plated on 60-mm
dishes 24 hours before transfection at a density to reach
80% optical density at the day of transfection and incu-
bated for 48 hours with a mixture of 7.5 lg plasmid DNA
and 5 lg lipid reagent (Metafectene; Biontex, Munich,
Germany) according the recommendations of the manu-
facturer. After this period, stably transfected cells were
selected by 400 lg/mL hygromycin B (Invitrogen) and
identified by fluorescence microscopy. Several healthy
clones were pooled and further expanded in medium
containing 400 lg/mL hygromycin B and maintained at
200 lg/mL.
Measurement of cell survival at high-urea concentrations
After pretreatment with hypertonic medium or with
10 lmol/L 12-PGJ2, IMCD3 wild-type cells were ex-
posed to medium containing 400 mmol/L urea for
24 hours. Transfected IMCD3 cells were grown to
confluence and also incubated in medium containing
400 mmol/L urea for 24 hours. After this period, detached
cells were aspirated, and adherent cells were treated with
trypsin and both fractions counted in a hemocytometer.
Cell survival was assessed as the number of adherent cells
expressed as the fraction of all (adherent + detached)
cells [7].
Northern blot analysis
Total RNA from dissected renal papillae and from
IMCD3 cells was recovered by homogenization in
TRI-Reagent (PeqLab, Erlangen, Germany) accord-
ing to the manufacturer’s recommendations. Aliquots
of 20 lg were run on 1% agarose/formaldehyde
gels, transferred to Nylon membranes (Hybond N+;
Amersham, Freiburg, Germany), and immobilized by
UV-crosslinking. Digoxigenin-labeled cDNA probes to
HSP70 and BGT1 were prepared by random primed ex-
tension of human HSP70 cDNA [22] or canine BGT1
cDNA [23] in the presence of digoxigenin-dUTP and
desoxynucleoside-triphosphates (NTPs) as described [7].
Non-radioactive hybridization and detection procedures
were performed as described previously [7].
Western blot analysis
The renal papilla was homogenized in a solution con-
taining 8 mol/L urea in PBS (100 lL/10 mg tissue) using
a Potter-Elvehjem homogenizer. Cultured IMCD3 cells
were lysed by pipetting with 8 mol/L urea/PBS (75 lL/
60-mm dish). The lysates were centrifuged at 12,000g at
4◦C for 15 minutes, and the supernatant removed. The
protein concentration in the extracts was determined ac-
cording to Bradford [24] after a two-fold dilution in PBS.
Aliquots of 40 lg of protein were run on 10% sodium
dodecyl sulphate (SDS)-polyacrylamide gels and trans-
ferred to nitrocellulose. Immunodetection of HSP70,
HSC70, HSP60, HSP25, and b-actin was performed as
described previously [7, 25]. Expression of BGT1 was
monitored by incubating the membranes overnight at 4◦C
with a polyclonal anti-BGT1 antibody (BioTrend, Ham-
burg, Germany) 1:1000 in a solution containing 5% (w/v)
non-fat dry milk in PBS/0.1% Tween-20). After extensive
washing with PBS/Tween-20 and incubation with appro-
priate secondary antibody, the immunocomplexes were
visualized by chemiluminescence (Pierce, Rockford, IL,
USA). Abundance of AR was determined by polyclonal
anti-rat AR (kindly provided by Dr. P. Kador, Dept. of
Pharmaceutical Sciences, University of Nebraska, NE,
USA) 1:10,000 in PBS/0.1% Tween-20 containing 10%
(v/v) goat serum, 1-hour incubation at room temperature
followed by exposure to peroxidase-conjugated donkey
anti-goat immunoglobulin (Ig)G (Dianova, Hamburg,
Germany) 1:10,000; 1-hour incubation at room temper-
ature, and detection by chemiluminescence. Bands were
quantified by densitometric analysis (Image J software,
National Institutes of Health, Bethesda, MD, USA).
TUNEL staining
TUNEL staining was performed on 4-lm thick paraffin
sections. Briefly, sections were deparaffinized, permeabi-
lized for 15 minutes with 0.1% Triton X-100/0.1% sodium
citrate, pH 6.0 at 4◦C, and extensively washed with PBS.
434 Neuhofer et al: COX-2 inhibition and papillary apoptosis
TUNEL-positive cells were identified by in situ cell death
detection kit (Roche, Mannheim, Germany) according
the manufacturers’ recommendations. Positive controls
were treated with DNAse I and processed as described
above. For negative controls, terminal deoxynucleotidy-
transferase was omitted. Finally, the sections were coun-
terstained with hematoxylin and mounted.
Measurement of caspase-3 activity
Dissected papillae and pieces of outer cortex were ho-
mogenized at 4◦C in a solution containing 50 mmol/L
HEPES, pH 7.4, 5 mmol/L CHAPS, and 5 mmol/L DTT
(10:1 v/w) using a Potter-Elvehjem homogenizer and
cleared by centrifugation at 12,000g at 4◦C for 15 min-
utes. Relative caspase-3 activity in the lysates was de-
termined by a colorimetric assay using paranitroanilin
(pNA)-conjugated Asp-Glu-Val-Asp (DEVD)-caspase-
3 substrate according to the recommendations of the
manufacturer (Promega, Madison, WI, USA). Caspase-
3 activity was monitored spectrophotometrically by
increase in A405 and normalized to the protein concentra-
tion in the lysates and expressed as nmol pNA released
per mg of protein in 1 hour.
Electron microprobe analysis
Cryosections (∼1 lm) were obtained from the tip of
the papilla in an ultracryomicrotome (Ultrotome V; LKB,
Bromma, Sweden) at −80◦C. Sections were freeze-dried
at −80◦C and 10−6 mbar overnight, warmed to about
40◦C in the freeze-drier, and then transferred rapidly
into a scanning transmission electron microscope (S150;
Cambridge Instruments, Cambridge, UK) equipped with
an energy-dispersive x-ray detecting system (Link, High
Wycomb, UK). Areas (∼1 lm2) were analyzed in the nu-
clei of papillary collecting duct cells and in the intersti-
tium. The acceleration voltage was 20 kV and the probe
current 0.3 nA. The emitted x-rays were analyzed in the
0.3–20.0 keV energy range. Electrolyte concentrations in
mmol/kg wet weight (wt) were obtained by procedures
described in detail elsewhere [1].
Urine analysis
Analyses were performed on urine collected for
24 hours before the beginning of the experiment, at weeks
1 and 2, and during the final 24-hour dehydration period
(week 3) in metabolic cages. Urine osmolality was deter-
mined by vapor pressure osmometer. Urea concentration
was measured using a commercially available colorimet-
ric assay (Sigma, Deisenhofen, Germany).
Statistical analysis
Differences between the groups were tested for signif-
icance using Student t test for independent samples. P <
0.05 was regarded as significant.
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Fig. 1. Urine osmolality in rats with free access to water before the
experiment, at weeks 1 and 2 during rofecoxib or control treatment, or
after 3 weeks of rofecoxib or control treatment during water deprivation
for 24 hours.
RESULTS
Effect of COX-2 inhibition on urine osmolality
and interstitial tonicity
Chronic COX-2 inhibition had no effect on urine os-
molality in rats with free access to water. However,
during water restriction, urine osmolality was about
300 mOsm/kg H2O higher in rofecoxib-treated animals
(Fig. 1). Further analysis of urine composition revealed
that this increment in urinary osmolality was due to
higher urea concentrations (755 ± 90 mmol/L in vehicle-
treated rats versus 1066 ± 79 mmol/L in rofecoxib-treated
animals (Fig. 2A). In agreement with these observations,
the sum of papillary interstitial electrolyte concentrations
(i.e., the interstitial tonicity), was not affected by rofe-
coxib treatment (Fig. 2B). Accordingly, intracellular ionic
strength was not different between control and rofecoxib-
treated rats (Fig. 2C). Together, COX-2 inhibition was as-
sociated with higher urine osmolality during dehydration
due to higher urea concentrations.
Effect of COX-2 inhibition on expression
of osmosensitive genes
Western blot analyses on homogenates of papillary tis-
sue showed that HSP70 expression was reduced by 50%
in rofecoxib-treated rats (Fig. 3). This reduction in HSP70
expression was accompanied by a decrease in HSP70
mRNA abundance, suggesting that down-regulation of
HSP70 transcription leads to reduced HSP70 levels
(Fig. 4). The expression of other osmoprotective genes
(i.e. AR and HSP25), was not affected by rofecoxib. In
addition, the expression of other chaperones investigated
and that of b-actin were not significantly different be-
tween rofecoxib and vehicle-treated animals. In contrast,
BGT1 abundance was increased by 65% in rats treated
with the COX-2 inhibitor (Fig. 3).
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Fig. 2. Interstitial and urinary solute concen-
trations after water deprivation for 24 hours
in rats receiving rofecoxib or control treat-
ment for 3 weeks. Urinary urea concentration
(A), mean ± SEM from four 24-hour urinary
collections. Interstitial (B) and intracellular
(PCD cells) (C) electrolyte concentrations as
determined by electron microprobe analysis.
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Fig. 3. Expression of osmosensitive genes in
rats after 3 weeks rofecoxib or control treat-
ment. Rats received rofecoxib (5 mg/kg/d) or
control suspension in the drinking water for
3 weeks. Thereafter, papillary expression of
the respective genes was determined by West-
ern blot analysis. (A) Representative blots of
four animals per group are shown. (B) Quan-
tified data from densitometric analyses. N =
4, mean ± SEM; ∗P < 0.05 vs. control.
COX-2 inhibition induces papillary apoptosis in
water-deprived rats
Rats received rofecoxib or control suspension for three
weeks and were then water-deprived for 24 hours. There-
after, both cortical and papillary tissue was examined for
TUNEL-positive cells. In the isosmotic cortex, TUNEL-
positive cells were absent in both glomeruli and tubular
epithelial cells after any treatment (Fig. 5). In contrast,
in papillary sections, numerous TUNEL-positive nuclei
(red staining) were detectable in rofecoxib-treated ani-
mals that localized primarily to papillary collecting duct
(PCD) cells (Fig. 5). Papillary collecting duct (PCD) cells
were identified based on their proximity to the PCD lu-
men and their round-shaped nuclei, which is typical for
PCD cells in contrast to cells of the thin limbs, endothelial
or interstitial cells. In agreement with the assumption that
chronic COX-2 inhibition might cause papillary apoptosis
during water deprivation, caspase-3 activity in papillary
homogenates was significantly higher compared to con-
trol (Fig. 6), whereas no effect was detectable in cortical
homogenates. There was no evidence of papillary apop-
tosis in non-dehydrated, rofecoxib-treated animals (not
shown).
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Fig. 4. Northern blot analysis of papillary heat shock protein 70
(HSP70) mRNA expression in rofecoxib- or control-treated rats. A
representative blot is shown. Equal RNA loading was confirmed by
ethidium bromide staining of the gel.
Effect of ∆12-PGJ2 on HSP70 expression and cell
survival at high-urea concentrations in vitro
Because 12-PGJ2 is excreted in significant amounts in
human urine and since this compound potently induces
436 Neuhofer et al: COX-2 inhibition and papillary apoptosis
A B
C D
Fig. 5. Papillary apoptosis in rofecoxib-treated rats. Rats receiving
rofecoxib (5 mg/kg/d) or control suspension for 3 weeks were wa-
ter deprived for 24 hours. Thereafter, apoptotic cells were identi-
fied by deoxynucleotidy-transferase-mediated dUTP nick-end labeled
(TUNEL) staining. Apoptotic nuclei are red. (A and C) Rofecoxib-
treated animals; (B and, D) control animals; A and B, cortex; C and D,
medulla. The bars represent 100 lm.
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Fig. 6. Papillary apoptosis in rofecoxib-treated rats. Rats receiving ro-
fecoxib (5 mg/kg/d) or control suspension for 3 weeks were water de-
prived for 24 hours. Thereafter, renal papillary and cortical apoptosis
was assessed in homogenates derived from papilla or cortex by the re-
lease of pNA from DEVD-pNA, which served as a specific caspase-3
substrate. N = 4; mean ± SEM; ∗P < 0.05 vs. control.
HSP70 in several cells, we tested the effect of 12-PGJ2
pretreatment on HSP70 expression and urea resistance
in murine IMCD3 cells. Both Northern and Western blot
analyses demonstrated that 12-PGJ2 dramatically in-
creased HSP70 expression compared to vehicle-treated
controls (Figs. 7 and 8). The abundance of BGT1, how-
ever, was not affected. Furthermore, cell survival after
a 24-hour exposure to 400 mmol/L urea in the medium
was significantly enhanced in 12-PGJ2 pretreated cells
(Fig. 8).
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Fig. 7. Effect of ∆12-PGJ2 on heat shock protein 70 (HSP70)- and
BGT1-mRNA abundance in IMCD3 cells. IMCD3 cells were incubated
for 4 hours with 10 lmol/L 12-PGJ2, reincubated for 4 hours in nor-
mal medium, and subsequently assayed for HSP70- or BGT1-mRNA
expression by Northern blot analysis. Three independent experiments
are shown. Equal RNA-loading was confirmed by ethidium bromide
staining of the gel.
To further confirm that this increase in urea resistance
was causally linked to elevated HSP70 levels, HSP70
was overexpressed stably in the IMCD3 cell line. GFP-
fluorescence showed that the majority of the cells ex-
pressed the transgene (Fig. 9A) or the empty vector
(Fig. 9B). Compared with mock-transfected cells, both
HSP70 expression (Fig. 9C) and cell survival after incuba-
tion for 24 hours in medium containing 400 mmol/L urea
were significantly higher in IMCD3-HSP70 cells (Fig. 10).
Effect of COX-2 inhibition on expression of osmosensi-
tive genes and survival in hyperosmolar medium in vitro
To evaluate the effect of COX-2 on the expression
of HSP70, BGT1, and AR, IMCD3 cells were incu-
bated for 48 hours in hypertonic medium (final os-
molality 500 mOsm/kg H2O by NaCl addition) in the
presence or absence of the highly specific COX-2 in-
hibitor NS398. NS398 was used because this compound
has improved solubility in aqueous media compared to
rofecoxib. Interestingly, the NaCl-induced HSP70 expres-
sion was strongly reduced in NS398-treated cells com-
pared to vehicle treated cells (Fig. 11), while no significant
effect on AR and BGT1 levels was detectable. COX-2
inhibition had no effect on survival of confluent IMCD3
monolayers in the hypertonic medium (not shown), but
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Fig. 8. Effect of ∆12-PGJ2 pretreatment on heat shock protein 70
(HSP70) expression and survival of IMCD3 cells at high urea con-
centrations. IMCD3 cells were exposed to 10 lmol/L 12-PGJ2 or the
same volume of the vehicle (methylacetate) for 4 hours. After reincu-
bation for 20 hours in normal medium, the cells were either processed
for HSP70 expression by Western blot analysis (a representative im-
munoblot is shown) or incubated in medium containing 400 mmol/L
urea for 24 hours. Thereafter, the fraction of surviving cells was deter-
mined. Mean ± SEM for 4–6 experiments. ∗P < 0.05 vs. vehicle-treated
cells.
Fig. 9. Effect of heat shock protein 70 (HSP70) overexpression on urea
resistance in IMCD3 cells. IMCD3 cells were stably transfected with
HSP70 expression construct or with empty vector. (A and B) Fluores-
cence microscopy for GFP in HSP70 overexpressing (A) and mock-
transfected (B) cells. (C) Immunoblot staining for HSP70 and b-actin
in the respective cells.
was associated with reduced proliferation of subconfluent
IMCD3 cells in hyertonic medium (Fig. 12).
We have demonstrated previously that pretreatment
of renal papillary cells with hypertonic medium (NaCl
addition) protects against subsequent exposure to high
Fig. 10. Effect of heat shock protein 70 (HSP70) overexpression on
survival of IMCD3 cells at high urea concentrations. The respective
cells were exposed to medium containing 400 mmol/L urea for 24 hours.
Thereafter, the fraction of surviving cells was determined. Mean ± SEM
for 4–6 experiments. ∗P < 0.05 vs. mock-transfected cells.
urea concentrations and that this effect is mediated by
HSP70 [7]. Therefore, IMCD3 cells were incubated for
48 hours in hypertonic medium (500 mOsm/kg H2O by
NaCl addition) in the presence or absence of 10 lmol/L
NS398 and subsequently exposed to an additional
400 mmol/L urea. After this period, the number of surviv-
ing cells was determined. As shown in Figure 13, the pro-
tective effect of hypertonic pretreatment on subsequent
urea exposure was significantly reduced in cells treated
with the COX-2 inhibitor.
DISCUSSION
Long-term use of non-steroidal anti-inflammatory
drugs may be associated with papillary injury and deteri-
oration of renal function [26]. Although selective COX-2
inhibitors seem to be beneficial with regard to gastroin-
testinal complications after long-term use [27], possible
renal side effects have received relatively less attention.
In particular, in dehydrated subjects, the use of COX-
2 inhibitors was associated with a deterioration of renal
function or even acute renal failure [28–30].
The renal medulla is a prominent site for the synthe-
sis of prostanoids that act close to their site of formation
(i.e., by paracrine or autocrine mechanisms), regulating a
variety of functions including renal medullary blood flow
as well as water and solute transport along the nephron
[16–18]. In particular, during dehydration, when the renal
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Fig. 11. Effect of cyclooxygenase-2 (COX-2)
inhibition on tonicity-induced expression of
heat shock protein 70 (HSP70), BGT, and AR.
IMCD3 cells were kept in isotonic medium
(Iso, 300 mOsm/kg H2O) or incubated for
48 hours in hypertonic medium (500 mOsm/kg
H2O by NaCl addition) in the presence (NaCl
+ NS398) or absence (NaCl + vehicle) of
10 lmol/L NS398. Thereafter, expression of
HSP70, BGT1, and AR were determined by
Western blot analysis. (A) Relative abun-
dance of the respective proteins. Mean ± SEM
of 4 experiments; P < 0.05 vs. NaCl + vehicle.
(B) Representative immunoblots are shown.
To demonstrate equal protein loading, the
blots were also probed for b-actin.
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Fig. 12. Effect of cyclooxygenase-2 (COX-2) inhibition on prolifera-
tion of IMCD3 cells in hypertonic medium. IMCD3 cells were plated at
a density of 1 × 105 cells per 60-mm dish. One day later, the cells were
switched to hypertonic medium (+ 100 mmol/L NaCl) in the presence
of 10 lmol/L NS398 () or vehicle (same volume of ethanol; ) or kept
in isotonic medium (). The number of cells was determined daily as
described in Methods. Mean ± SEM for 4 experiments; ∗P < 0.05 vs.
Isotonic; #P < 0.05 vs. NaCl + vehicle.
concentrating mechanism is stimulated and papillary in-
terstitial tonicity increases, COX-2 is induced [14, 15] and
seems to account for the majority of prostanoids formed
in the renal medulla. In agreement with this assumption,
COX-2 expression was detected in both papillary inter-
stitial and collecting duct cells and is induced by hyper-
tonic stress in vivo and in vitro [14, 15]. This enhanced
production of COX-2–derived prostanoids at high extra-
cellular solute concentrations could make a major con-
tribution to maintenance of normal cellular functions of
medullary cells. Because the incidence of medullary in-
jury is exacerbated by dehydration [15, 28–30], it seems
likely that medullary COX-2–derived prostanoids con-
tribute decisively to cell homeostasis under this condition.
The present experiments demonstrate that chronic ad-
ministration of the highly selective COX-2 inhibitor rofe-
coxib was associated with renal papillary apoptosis during
dehydration. These observations are in agreement with
a recent study showing that chronic COX-2 inhibition is
associated with papillary apoptosis in water-deprived rab-
bits [15]. In that study, however, the major site of damage
were the interstitial cells, while in the present series of ex-
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Fig. 13. Effect of cyclooxygenase-2 (COX-2) inhibition on the protec-
tive effect of hypertonic pretreatment against high urea concentrations.
IMCD3 cells were were kept in isotonic medium (Iso, 300 mOsm/kg
H2O) or incubated for 48 hours in hypertonic medium (500 mOsm/kg
H2O by NaCl addition) in the presence (NaCl + NS398) or absence
(NaCl + vehicle) of 10 lmol/L NS398. Thereafter, an additional
400 mmol/L urea was added and, after 24 hours, the number of sur-
viving cells was determined. Mean ± SEM for 4 experiments; ∗P < 0.05
vs. NaCl + vehicle.
periments, primarily PCD cells were affected. However,
we cannot completely exclude the possibility that also in-
terstitial cells or cells of the thin limbs were damaged. This
discrepancy might be explained by species-specific differ-
ences (rabbits vs. rats). Alternatively, distinct actions or
toxicities of the experimental compound SC58236, which
was used in the study of Hao et al, and rofecoxib, which
was employed in the present experiments, may account
for these different observations.
The mechanism by which COX-2 protects medullary
cells may be many-fold. Hao et al has demonstrated
that hypertonicity induces a COX-2–dependent, NF-jB–
driven survival mechanism in medullary interstitial cells
[15]. Another investigation demonstrated that J-series
cyclopentenone PGs formed in a COX-2–dependent
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manner increase proliferation and survival of colorec-
tal cancer cells [31]. The downstream effector that con-
fers stress tolerance, however, is still unknown. In the
present experiments we demonstrated that COX-2 in-
hibition was associated with a 50% reduction in inner
medullary HSP70 content and with papillary apoptosis
during dehydration. A large body of evidence indicates
that one mode of action of PGs is mediated by cell surface
receptors and subsequent changes in the level of intracel-
lular second messengers. In addition to this type of signal-
ing, cyclopentenone prostaglandins like 12-PGJ2, which
contain a a,b-unsaturated carbonyl group in their cy-
clopentone ring, translocate to the nucleus and associate
with nuclear proteins [20]. Apart from their ability to bind
and activate peroxisome proliferator–activated receptor
c [32], these compounds activate HSF1 directly and in-
duce the expression of HSP70 [20, 21], which confers re-
sistance against a variety of stressful situations [7, 33]. In
agreement, preconditioning of smooth muscle cells with
cyclopentenone prostaglandins not only induces HSP70
but also confers resistance against oxidized low-density
lipoprotein-mediated cell damage [34]. Consistent with
these data, the present study showed that preincubation
of IMCD3 cells with 12-PGJ2 increased both HSP70
expression and resistance against high urea concentra-
tions and that this protective effect was linked causally to
higher HSP70 levels. Although we did not measure the
excretion of 12-PGJ2 in urine, the present data are in
agreement with previous observations in which COX in-
hibitors reduced urinary 12-PGJ2 excretion [19]. Based
on the expression and distribution of cyclooxygenases
in the renal papilla, it is very likely that 12-PGJ2 orig-
inates from papillary interstitial and/or collecting duct
cells and acts in an auto- or paracrine manner. Because
12-PGJ2 is highly membrane permeant and acts via in-
tracellular transcription factors, we speculate that 12-
PGJ2 excreted in urine originates from papillary cells and
should thus be available for HSP70 induction. However,
we cannot completely exclude that urinary 12-PGJ2 is
derived from prepapillary structures because there is no
data available addressing this issue. However, even if the
latter is the case, 12-PGJ2 in the PCD lumen should be
available for HSP70 induction, at least in PCD cells, be-
cause 12-PGJ2 readily enters the cells and activates HSF
directly. Furthermore, the present in vitro data strongly
suggest that COX-2 activity is required for HSP70 induc-
tion by high salt concentrations in IMCD cells (Fig. 11).
These data are in agreement with previous investigations
in which over-expression of HSP70 robustly increased the
resistance of MDCK cells against high urea concentra-
tions [7], a phenomenon which is mediated at least in part
by the chaperoning effects of HSP70 on cellular enzymes
at high and protein-destabilizing urea concentrations [8].
Another example of HSP70-mediated cell protection rel-
evant to the kidney was presented by Bidmon et al [35].
In this study, HSP70 diminished Na,K-ATPase redistribu-
tion and restored proximal tubular structure after renal
ischemia.
In addition, HSP70 may suppress apoptosis in stressed
cells by interaction with both Apaf-1 and apoptosis-
inducing factor [33, 36]. This, and the chaperoning effect
of HSP70, might be of special relevance for the mecha-
nism of papillary apoptosis seen here: on the one hand,
COX-2 inhibition increased urinary and, thus, presum-
ably also papillary interstitial urea concentrations, while,
on the other hand, this maneuver was associated with a re-
duction of urea-protective mechanisms (i.e., diminished
papillary HSP70 expression).
Down-regulation of HSP70 expression in rofecoxib-
treated animals was associated with enhanced abundance
of BGT1. Both HSP70 and the trimethylamine betaine
protect intracellular proteins from denaturation during
cell stress [37–39]. Experiments on 3T3 and MDCK cells
demonstrated that increased intracellular betaine con-
tents reduced the requirement for HSP70 in cells exposed
to osmotic or heat stress [37, 40]. It is thus conceivable that
rofecoxib-induced reduction in medullary HSP70 con-
tents results in up-regulation of BGT1 to stimulate cellu-
lar betaine accumulation. Betaine is both a “compatible”
and “counteracting” osmolyte (i.e., even high intracellu-
lar betaine concentrations are metabolically neutral and
help to counteract the deleterious effects of high urea
concentrations). However, the present observation of an
increased incidence of apoptosis in the inner medulla of
rofecoxib-treated rats suggests that enhanced expression
of the betaine transporter BGT1 does not fully compen-
sate for the reduced inner medullary HSP70 contents.
Interestingly, inhibition of COX-2 for only 3–4 days in
mice was associated with reduced expression of BGT1
[41]. Hence, changes in the expression of BGT1 caused by
treatment with a COX-2 inhibitor may be species-specific
or/and follow a well-defined time course.
The enhanced urine concentrating ability in rofecoxib-
treated animals is in agreement with previously published
data showing that inhibition of prostaglandin synthesis
reduces urine flow and increases urine osmolality. This
effect is attributed to the attenuation of vasopressin-
antagonizing action of medullary prostaglandins [42,
43]. In the inner medulla of a number of species, urea
concentrations greatly exceed the corresponding NaCl
concentrations. High urea concentrations in the inner
medulla stimulate the countercurrent system by medi-
ating water abstraction along the thin descending limb of
Henle’s loop. As a consequence, tubular NaCl concen-
trations rise along this nephron segment. As the tubu-
lar fluid moves up the thin ascending limb of Henle’s
loop, NaCl can exit passively down a favorable concen-
tration gradient, causing the interstitial NaCl concen-
trations to rise and the osmolality of the tubular fluid
to fall below that of the surrounding interstitium. The
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occurrence of papillary opoptosis in the present exper-
iments is probably due to both higher interstitial urea
and lower intracellular HSP70 concentrations, because
there was no difference in papillary interstitial electrolyte
cncentration.
CONCLUSION
The present experiments demonstrate that chronic in-
hibition of COX-2 is associated with reduced HSP70 ex-
pression in the renal papilla in vivo and in IMCD3 cells
exposed to osmotic stress in vitro. These effects were as-
sociated with both papillary apoptosis in vivo during wa-
ter deprivation and reduced resistance against high urea
concentrations in IMCD3 cells in vitro. This effect might
be mediated by a reduction in COX-2–derived HSP70-
inducing products such as 12-PGJ2 and concomitantly
increased susceptibility to high extracellular solute con-
centrations.
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